Ashok M. Raichur

Prof. Dr. Ashok M. Raichur


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2018 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RNReema Narayan
Reema Narayan
UNUsha Y Nayak
Usha Y Nayak
ARAshok M. Raichur
Ashok M. Raichur
Sanjay GargSanjay Garg
Sanjay Garg
Recent advancements in drug delivery technologies utilizing a variety of carriers have resulted in a path-breaking revolution in the approach towards diagnosis and therapy alike in the current times. Need for materials with high thermal, chemical and mechanical properties have led to the development of mesoporous silica nanoparticles (MSNs). These ordered porous materials have garnered immense attention as drug carriers owing to their distinctive features over the others. They can be synthesized using a relatively simple process, thus making it cost effective. Moreover, by controlling the parameters during the synthesis; the morphology, pore size and volume and particle size can be transformed accordingly. Over the last few years, a rapid increase in research on MSNs as drug carriers for the treatment of various diseases has been observed indicating its potential benefits in drug delivery. Their widespread application for the loading of small molecules as well as macromolecules such as proteins, siRNA and so forth, has made it a versatile carrier. In the recent times, researchers have sorted to several modifications in the framework of MSNs to explore its potential in drug resistant chemotherapy, antimicrobial therapy. In this review, we have discussed the synthesis of these multitalented nanoparticles and the factors influencing the size and morphology of this wonder carrier. The second part of this review emphasizes on the applications and the advances made in the MSNs to broaden the spectrum of its use especially in the field of biomedicine. We have also touched upon the lacunae in the thorough understanding of its interaction with a biological system which poses a major hurdle in the passage of this carrier to the clinical level. In the final part of this review, we have discussed some of the major patents filed in the field of MSNs for therapeutic purpose.

1 January 2011 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
TPT.C. Prathna
T.C. Prathna
Natarajan ChandrasekaranNatarajan Chandrasekaran
Natarajan Chandrasekaran
ARAshok M. Raichur
Ashok M. Raichur
AMAmitava Mukherjee
Amitava Mukherjee

20 February 2009 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
ATA. Tripathy
A. Tripathy
ARAshok M. Raichur
Ashok M. Raichur
Natarajan ChandrasekaranNatarajan Chandrasekaran
Natarajan Chandrasekaran
TPT. C. Prathna
T. C. Prathna
AMAmitava Mukherjee
Amitava Mukherjee

1 September 2004 in Applied Surface Science
Verified
Journal Article
Closed access
SGS Guruvenket
S Guruvenket
GRG.Mohan Rao
G.Mohan Rao
MKManoj Komath
Manoj Komath
ARAshok M. Raichur
Ashok M. Raichur

1 June 2001 in Separation and Purification Technology
Verified
Journal Article
Closed access
ARAshok M. Raichur
Ashok M. Raichur
MBM Jyoti Basu
M Jyoti Basu

1 March 2010 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
ARAswathy Ravindran
Aswathy Ravindran
ASAnupam Singh
Anupam Singh
ARAshok M. Raichur
Ashok M. Raichur
Natarajan ChandrasekaranNatarajan Chandrasekaran
Natarajan Chandrasekaran
AMAmitava Mukherjee
Amitava Mukherjee